Gelomics
PrivateLast Round
Grant
Jun 4, 2025
Total Funding Raised
$2.82M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Gelomics operates in Healthcare & Life Sciences and is based in Kelvin Grove. Its latest recorded funding round was a Grant round in June 2025.
Gelomics is a biotechnology company that develops 3D cell culture technologies and tunable extracellular matrices to create in vitro human tissue models for drug discovery and disease modeling.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gelomics Comparables
Compare Gelomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inventia Life Science | 85% | |
| Manchester BIOGEL | 85% | |
| PepGel | 84% |
For institutional investors. Book with your work email.
Gelomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 4, 2025 | ||||
| Seed | Jul 4, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gelomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Angel Loop | Seed |
| Jelix Ventures | Seed |
| Queensland Investment Corporation (QIC) | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 85% MoM.
- Jul 24, 2026
Monthly visitors increased 1513% MoM.
For institutional investors. Book with your work email.
Gelomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gelomics's valuation, stock price, and market status.
Is Gelomics a public or private company?
Gelomics is a private company.
What is the current stock price of Gelomics?
Gelomics is a private company, so its shares have no public market price. Caplight tracks Gelomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gelomics worth (valuation)?
Valuation information for Gelomics is not publicly available.
Can I buy Gelomics stock?
Gelomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gelomics's last funding round?
Gelomics's most recent funding round was Grant on June 4, 2025.
Who are the main investors in Gelomics?
Key investors in Gelomics include Jelix Ventures.
Will Gelomics IPO soon?
No public IPO plans have been announced for Gelomics.
How can I track Gelomics secondary market activity?
Caplight tracks bids, offers, and trades in Gelomics's shares on secondary markets.